In silico and in vitro assessment of anti-Trypanosoma cruzi efficacy, genotoxicity and pharmacokinetics of pentasubstituted pyrrolic Atorvastatin-aminoquinoline hybrid compounds-Reference-Cited by-同舟云学术

In silico and in vitro assessment of anti-Trypanosoma cruzi efficacy, genotoxicity and pharmacokinetics of pentasubstituted pyrrolic Atorvastatin-aminoquinoline hybrid compounds

Published:2023-06 Issue: Volume:242 Page:106924
ISSN:0001-706X
Container-title:Acta Tropica
language:en
Short-container-title:Acta Tropica

Author:

Araujo-Lima Carlos Fernando,Carvalho Rita de Cássia Castro,Peres Raiza Brandão,Fiuza Ludmila Ferreira de Almeida,Galvão Bárbara Verena Dias,Castelo-Branco Frederico S.,Bastos Mônica Macedo,Boechat Nubia,Felzenszwalb Israel^ORCID,Soeiro Maria de Nazaré Correia

Publisher

Elsevier BV

Subject

Infectious Diseases,Parasitology,Insect Science,Veterinary (miscellaneous)

Reference52 articles.

1. Repurposing strategy of atorvastatin against trypanosoma cruzi: in vitro monotherapy and combined therapy with benznidazole exhibit synergistic trypanocidal activity;Araujo-Lima;Antimicrob. Agents Chemother.,2018

2. Atorvastatin downregulates in vitro methyl methanesulfonate and cyclophosphamide alkylation-mediated cellular and DNA injuries;Araujo-Lima;Oxid. Med. Cell Longev.,2018

3. Arylimidamide DB766, a potential chemotherapeutic candidate for Chagas’ disease treatment;Batista;Antimicrob. Agents Chemother.,2010

4. Pyrrole: a resourceful small molecule in key medicinal hetero-aromatics;Bhardwaj;RSC Adv.,2015

5. Use of toxicogenomics to understand mechanisms of drug-induced hepatotoxicity during drug discovery and development;Blomme;Toxicol. Lett. Toxicogenom. Clin. Toxicol.,2009

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antitrypanosomal Activity of 1,2,3-Triazole-Based Hybrids Evaluated Using In Vitro Preclinical Translational Models;Biology;2023-09-08

2. Antiplasmodial, Trypanocidal, and Genotoxicity In Vitro Assessment of New Hybrid α,α-Difluorophenylacetamide-statin Derivatives;Pharmaceuticals;2023-05-24